NCT04643002
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04643002
Title Isatuximab in Combination With Novel Agents in RRMM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NOR | ITA | ISR | GRC | FRA | DEU | AUS

Facility Status City State Zip Country Details
Winship Cancer Institute, Emory University- Site Number : 8400010 RECRUITING Atlanta Georgia 30322-0001 United States Details
University of Illinois-Chicago - College of Medicine- Site Number : 8400007 COMPLETED Chicago Illinois 60612 United States Details
University of Michigan Health System - Ann Arbor- Site Number : 8400004 RECRUITING Ann Arbor Michigan 48109 United States Details
Roswell Park Cancer Institute- Site Number : 8400008 RECRUITING Buffalo New York 14263 United States Details
Investigational Site Number : 0360006 RECRUITING Wollongong New South Wales 2500 Australia Details
Investigational Site Number : 0360002 RECRUITING Melbourne Victoria 3065 Australia Details
Investigational Site Number : 0360001 RECRUITING Richmond Victoria 3121 Australia Details
Investigational Site Number : 2500002 RECRUITING Lille 59037 France Details
Investigational Site Number : 2500001 RECRUITING Nantes 44093 France Details
Investigational Site Number : 2500004 RECRUITING Paris 75015 France Details
Investigational Site Number : 2500003 RECRUITING Paris 75651 France Details
Investigational Site Number : 2760006 RECRUITING Frankfurt 60590 Germany Details
Investigational Site Number : 2760008 RECRUITING Lübeck 23538 Germany Details
Investigational Site Number : 3000002 RECRUITING Athens 106 76 Greece Details
Investigational Site Number : 3000001 RECRUITING Athens 115 28 Greece Details
Investigational Site Number : 3760002 RECRUITING Jerusalem 9112001 Israel Details
Investigational Site Number : 3760003 RECRUITING Ramat Gan 5262100 Israel Details
Investigational Site Number : 3760001 RECRUITING Tel Aviv 6423906 Israel Details
Investigational Site Number : 3800001 RECRUITING Meldola Reggio Emilia 47014 Italy Details
Investigational Site Number : 5780001 RECRUITING Oslo 0450 Norway Details
Investigational Site Number : 6200001 RECRUITING Coimbra 3000-075 Portugal Details
Investigational Site Number : 6200002 RECRUITING Porto 4434-502 Portugal Details
Puerto Rico Medical Research Center- Site Number : 8400005 RECRUITING HATO REY Puerto Rico 00917 Puerto Rico Details
Investigational Site Number : 4100004 RECRUITING Seoul Seoul-teukbyeolsi 03722 South Korea Details
Investigational Site Number : 4100002 RECRUITING Seoul Seoul-teukbyeolsi 06351 South Korea Details
Investigational Site Number : 4100003 RECRUITING Seoul Seoul-teukbyeolsi 06591 South Korea Details
Investigational Site Number : 4100001 RECRUITING Seoul Seoul-teukbyeolsi 110-744 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field